CHM chimeric therapeutics limited

Ann: Presentation to investor webinar, page-3

  1. 8,324 Posts.
    lightbulb Created with Sketch. 3661
    This was an extremely insightful and heartfelt webinar. Rebecca has clearly been operating under difficult circumstances and has been hassled by shareholders about timelines and updates. I give her great credit for wanting to address this and doing so with such clarity. I get the impression that the brokers have been hovering over CHM like vultures. The only thing that is going to keep the company moving forward is positive data... and with that will come ("decent") financial support. The Pig's questions made for an interesting webinar... so thank you. Well done, Dr Bec, for addressing the circumstances that lead to missed timelines and the perceptions that evolve around governance.
    Last edited by Shellbell: 22/05/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $15.69K 3.919M

Buyers (Bids)

No. Vol. Price($)
26 21936206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 24685267 27
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.